Advertisement

Topics

Strosberg Sasso Sutts LLP Company Profile

15:14 EDT 20th June 2019 | BioPortfolio


News Articles [3 Associated News Articles listed on BioPortfolio]

Researchers observe rarest event in history of the universe

Despite Progress, Somatostatin Analogs Remain Frontline Standard in NETs

Jonathan R. Strosberg, MD, sheds light on the latest developments made in the complex treatment paradigm of gastroenteropancreatic neuroendocrine tumors.

Systemic Treatments for NETs: Whom to Treat and How to Sequence

During a recent panel discussion, neuroendocrine tumor experts Simron Singh, MD, MPH, and Jonathan R. Strosberg, MD, provided insight on which patients are the best candidates for these approved treat...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

More Information about "Strosberg Sasso Sutts LLP" on BioPortfolio

We have published hundreds of Strosberg Sasso Sutts LLP news stories on BioPortfolio along with dozens of Strosberg Sasso Sutts LLP Clinical Trials and PubMed Articles about Strosberg Sasso Sutts LLP for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Strosberg Sasso Sutts LLP Companies in our database. You can also find out about relevant Strosberg Sasso Sutts LLP Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record